Fund shareholders of Rocket Pharmaceuticals Inc
ISIN US77313F1066 · United States · LEI 549300R7VV82YUIN4Y93
- Fund shareholders
- 156
- Of which ETFs
- 26 130 other funds
- Value held
- ≈ 95.6M $ 95.5M $ · 29.9K €
- Share of capital
- 23.7 % of 109.8M shares on Jul 31, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| EQ/Common Stock Index Portfolio EQ Advisors Trust | 8,900 | 31.9K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| U.S. Small Cap Equity Fund RUSSELL INVESTMENT CO | 8,500 | 29.6K $ | 0.00 % | 0.01 % | as of Apr 30, 2026 ↗ |
| AST Small-Cap Equity Portfolio Advanced Series Trust | 8,070 | 28.9K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| CVT Russell 2000 Small Cap Index Portfolio Calvert Variable Trust, Inc. | 7,797 | 27.9K $ | 0.01 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Venerable Small Cap Index Fund Venerable Variable Insurance Trust | 6,947 | 24.9K $ | 0.01 % | 0.01 % | as of Mar 31, 2026 ↗ |
| PD Small-Cap Value Index Portfolio PACIFIC SELECT FUND | 6,601 | 23.6K $ | 0.02 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Nationwide Small Cap Index Fund Nationwide Mutual Funds | 6,333 | 22K $ | 0.01 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 6,041 | 30.3K $ | 0.04 % | 0.01 % | as of Feb 28, 2026 ↗ |
| Strategic Equity Allocation Trust John Hancock Variable Insurance Trust | 5,963 | 21.3K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| U.S. Small Cap Equity Fund RUSSELL INVESTMENT FUNDS | 5,700 | 20.4K $ | 0.01 % | 0.01 % | as of Mar 31, 2026 ↗ |
| SA U.S. Small Company Fund SA FUNDS INVESTMENT TRUST | 5,571 | 19.9K $ | 0.01 % | 0.01 % | as of Mar 31, 2026 ↗ |
| VANGUARD RUSSELL 3000 INDEX FUND VANGUARD SCOTTSDALE FUNDS | 5,568 | 27.9K $ | 0.00 % | 0.01 % | as of Feb 28, 2026 ↗ |
| VIP Extended Market Index Portfolio Variable Insurance Products Fund II | 5,536 | 19.8K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Voya VACS Index Series SC Portfolio Voya VARIABLE PORTFOLIOS INC | 5,423 | 19.4K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Ultra Russell2000 ProShares Trust | 5,247 | 26.3K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares UltraPro Russell2000 ProShares Trust | 5,225 | 26.2K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 4,990 | 25K $ | 0.03 % | 0.00 % | as of Feb 28, 2026 ↗ |
| iShares Total U.S. Stock Market Index Fund BlackRock Funds | 4,600 | 16K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| SA Multi-Managed Small Cap Portfolio SEASONS SERIES TRUST | 3,681 | 13.2K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Russell 2000 High Income ETF ProShares Trust | 3,669 | 18.4K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Morgan Stanley Pathway Small-Mid Cap Equity ETF MORGAN STANLEY PATHWAY FUNDS | 3,318 | 16.6K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Disciplined U.S. Small Cap Equity Portfolio GLENMEDE FUND INC | 3,251 | 11.3K $ | 0.36 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Small-Cap Equity Portfolio PACIFIC SELECT FUND | 3,226 | 11.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SmallCap Value Fund II Principal Funds, Inc | 2,724 | 9.5K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| EQ/Franklin Small Cap Value Managed Volatility Portfolio EQ Advisors Trust | 2,723 | 9.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 2,721 | 9.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 2,224 | 8K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Penn Series Small Cap Index Fund Penn Series Funds Inc | 2,200 | 7.9K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| EQ/Morgan Stanley Small Cap Growth Portfolio EQ Advisors Trust | 2,193 | 7.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 2,060 | 7.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| WisdomTree BioRevolution Fund WisdomTree Trust | 2,033 | 7.3K $ | 0.32 % | 0.00 % | as of Mar 31, 2026 ↗ |
| VIP Total Market Index Portfolio Variable Insurance Products Fund II | 1,959 | 7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust | 1,696 | 8.5K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Dimensional U.S. Core Equity 2 ETF Dimensional ETF Trust | 1,662 | 5.8K $ | 0.00 % | as of Apr 30, 2026 ↗ | |
| TIAA Separate Account VA-1 - Stock Index Account TIAA Separate Account VA-1 | 1,412 | 5.1K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Nationwide Fundamental All Cap Equity Portfolio Nationwide Mutual Funds | 1,411 | 4.9K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| LVIP Dimensional U.S. Core Equity 2 Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 1,401 | 5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| AZL DFA U.S. Core Equity Fund Allianz Variable Insurance Products Trust | 1,042 | 3.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ULTRA SMALL CAP PROFUND ProFunds | 957 | 3.3K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| New Covenant Growth Fund NEW COVENANT FUNDS | 932 | 3.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 870 | 3.1K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PD Small-Cap Growth Index Portfolio PACIFIC SELECT FUND | 823 | 2.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SmallCap Growth Fund I Principal Funds, Inc | 677 | 2.4K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 428 | 1.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 350 | 1.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 283 | 1K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 214 | 766.1 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 197 | 705.3 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 155 | 539.4 $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 118 | 422.4 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 98 | 350.8 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 87 | 435.9 $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 25 | 125.3 $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 23 | 82.3 $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Avantis Responsible U.S. Equity ETF American Century ETF Trust | 2 | 10 $ | 0.00 % | as of Feb 28, 2026 ↗ | |
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 29.9K € | 0.04 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 0.76 % | as of Apr 30, 2026 ↗ |
| Global X Genomics & Biotechnology ETF GLOBAL X FUNDS | 0.36 % | as of Feb 28, 2026 ↗ |
| Disciplined U.S. Small Cap Equity Portfolio GLENMEDE FUND INC | 0.36 % | as of Apr 30, 2026 ↗ |
| WisdomTree BioRevolution Fund WisdomTree Trust | 0.32 % | as of Mar 31, 2026 ↗ |
| VANGUARD MARKET NEUTRAL FUND VANGUARD MONTGOMERY FUNDS | 0.19 % | as of Mar 31, 2026 ↗ |
| Nuveen Life Small Cap Equity Fund TIAA-CREF Life Funds | 0.18 % | as of Mar 31, 2026 ↗ |
| Nuveen Quant Small Cap Equity Fund TIAA-CREF Funds | 0.15 % | as of Apr 30, 2026 ↗ |
| VANGUARD STRATEGIC SMALL-CAP EQUITY FUND VANGUARD HORIZON FUNDS | 0.15 % | as of Mar 31, 2026 ↗ |
| Federated Hermes MDT Small Cap Growth Fund Federated Hermes MDT Series | 0.13 % | as of Apr 30, 2026 ↗ |
| Federated Hermes MDT Small Cap Core Fund Federated Hermes MDT Series | 0.13 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 155 | +27 | 25,983,526 | +46.9 % |
| 2026Q1 | 128 | -22 | 17,693,045 | +7.8 % |
| 2025Q4 | 150 | -6 | 16,413,028 | -1.1 % |
| 2025Q3 | 156 | -34 | 16,593,053 | -42.2 % |
| 2025Q2 | 190 | -13 | 28,710,578 | -10.4 % |
| 2025Q1 | 203 | -24 | 32,038,450 | +3.0 % |
| 2024Q4 | 227 | -20 | 31,110,293 | -2.9 % |
| 2024Q3 | 247 | -2 | 32,043,505 | +4.3 % |
| 2024Q2 | 249 | +22 | 30,724,260 | +37.2 % |
| 2024Q1 | 227 | +2 | 22,399,938 | -14.0 % |
| 2023Q4 | 225 | 26,041,226 |
Institutional managers
190 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| RTW INVESTMENTS, LP | 17,687,772 | 63.3M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 7,834,795 | 28M $ | as of Mar 31, 2026 |
| CITIGROUP INC | 5,107,708 | 18.3M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 4,485,989 | 16.1M $ | as of Mar 31, 2026 |
| MAVERICK CAPITAL LTD | 3,567,372 | 12.8M $ | as of Mar 31, 2026 |
| Newtyn Management, LLC | 3,165,900 | 11.3M $ | as of Mar 31, 2026 |
| Nuveen, LLC | 3,128,753 | 11.2M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 3,118,124 | 11.2M $ | as of Mar 31, 2026 |
| AQR CAPITAL MANAGEMENT LLC | 3,069,930 | 11M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 3,038,715 | 10.9M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 2,189,256 | 7.8M $ | as of Mar 31, 2026 |
| D. E. Shaw & Co., Inc. | 2,169,625 | 7.8M $ | as of Mar 31, 2026 |
| Monaco Asset Management SAM | 2,058,303 | 7.4M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 2,020,108 | 7.2M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 1,721,116 | 6.2M $ | as of Mar 31, 2026 |
| UBS Group AG | 1,298,173 | 4.6M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 1,097,623 | 3.9M $ | as of Mar 31, 2026 |
| FEDERATED HERMES, INC. | 1,023,747 | 3.7M $ | as of Mar 31, 2026 |
| Point72 Asset Management, L.P. | 1,012,126 | 3.6M $ | as of Mar 31, 2026 |
| Opaleye Management Inc. | 955,000 | 3.4M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 859,874 | 3.1K $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 796,224 | 2.7M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 724,392 | 2.6M $ | as of Mar 31, 2026 |
| Prosight Management, LP | 683,856 | 2.4M $ | as of Mar 31, 2026 |
| Aberdeen Group plc | 664,821 | 2.4M $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Fund shareholders of Rocket Pharmaceuticals Inc". https://titelia.com/en/stocks/rocket-pharmaceuticals-inc-US77313F1066